All In Biotech

Drug Trial Radar · NCT04003350

The Effect of Prolonged Multimodal Analgesic Regimen on Post Hospital Discharge Opioid Use and Pain Control After Primary Total Knee Arthroplasty

Last checked: Nov 19, 2026Latest source record: Jul 1, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 216 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

216

Actual

Start

Dec 21, 2017

Primary completion

Nov 26, 2018

Study completion Mar 15, 2019

Sponsor

Lead sponsor
Rothman Institute OrthopaedicsAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jul 1, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

It is well recognized that a multimodal analgesia program targeting multiple pain pathways, is more effective for controlling pain during the hospital stay and in the acute postoperative period than monotherapy-based regimens, such as opioids only. This multimodal analgesic regimen also leads to reduce opioid consumption and its related side effects after hip and knee joint replacement procedures. One potential strategy to reduce the use of opioids after TKA is to administer a prolonged oral multimodal pain regimen that targets multiple pain pathways in the post hospital discharge period. This can be equal or more effective than the regimen of opioid prescriptions used after TKA. To the best of our knowledge, there have been no studies conducted that directly examine the effect of prolonged multimodal pain regimen after hospital discharge in primary TKA patients. PURPOSE: 1. To determine whether a prolonged multimodal pain regimen after discharge from primary TKA can provide equivalent or better pain control while reducing opioid consumption and, subsequently, opioid-related side effects. 2. To determine whether patient expectations and routine opioid prescription practices at the time of discharge from primary TKA impacts opioid consumption.

Conditions

  • Osteo Arthritis Knee

Interventions

  • OxycodoneDrug

    Patients are given, for up to 4 weeks, Oxycodone 5m PRN every four hours (up to 30 tablets)

  • TramadolDrug

    Patients are given, for up to 4 weeks, Tramadol 50mg PRN every 6 hours (up to 30 tablets)

  • TylenolDrug

    Tylenol 1000 mg: take as needed every 8 hours

  • MeloxicamDrug

    Meloxicam 15 mg as need once per day

  • GabapentinDrug

    •Gabapentin 200 mg with morning and evening Tylenol dose

  • MetaxaloneDrug

    Metaxalone 800mg TID

  • Esomeprazole 20mgDrug

    Esomeprazole 20mg daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Post-operative painTime frame: Postsurgery days 1-30
  2. Opioid related side effectsTime frame: post-surgery days 1-30

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Rothman Institute

    Philadelphia, Pennsylvania

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.